RS49826B - Postupak optičkog prečišćavanja preparata obogaćenog enantiomerom omeprazola - Google Patents

Postupak optičkog prečišćavanja preparata obogaćenog enantiomerom omeprazola

Info

Publication number
RS49826B
RS49826B YUP-376/96A YU37696A RS49826B RS 49826 B RS49826 B RS 49826B YU 37696 A YU37696 A YU 37696A RS 49826 B RS49826 B RS 49826B
Authority
RS
Serbia
Prior art keywords
enantiomerically enriched
compound
optical purification
enantiomer
racemate
Prior art date
Application number
YUP-376/96A
Other languages
English (en)
Inventor
Sverker VON UNGE
Original Assignee
Astra Aktiebolag.,
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20397468&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=RS49826(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astra Aktiebolag., filed Critical Astra Aktiebolag.,
Publication of YU37696A publication Critical patent/YU37696A/sh
Publication of RS49826B publication Critical patent/RS49826B/sr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/28Sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Postupak optičkog prečišćavanja preparata obogaćenog enantiomerom jedinjenja prema formuli 1a Ia naznačen time, što dalje obuhvata korake - tretiranja preparata obogaćenog enantiomerom jedinjenja prema formuli 1a u korist njegovog (+) uku (-) enantiomera, sa organskim rastvaračem izabranim od acetona, 2-butanona, etil acetata, etanola, acetonitrila ili toluena iz koga je selektivno staložen racemat pomenutog jedinjenja, - cedjenja staloženog racemata i - uklanjanja rastvarača da bi se dobio jedan enantiomer sa povećanom optičkom čistoćom. Prijava sadrži još 8 patentnih zahteva.
YUP-376/96A 1995-07-03 1996-06-19 Postupak optičkog prečišćavanja preparata obogaćenog enantiomerom omeprazola RS49826B (sr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9500817 1995-07-03

Publications (2)

Publication Number Publication Date
YU37696A YU37696A (sh) 1999-03-04
RS49826B true RS49826B (sr) 2008-08-07

Family

ID=20397468

Family Applications (1)

Application Number Title Priority Date Filing Date
YUP-376/96A RS49826B (sr) 1995-07-03 1996-06-19 Postupak optičkog prečišćavanja preparata obogaćenog enantiomerom omeprazola

Country Status (37)

Country Link
US (1) US5929244A (sr)
EP (2) EP1498416A1 (sr)
JP (1) JP4195507B2 (sr)
KR (1) KR100451078B1 (sr)
CN (1) CN1098261C (sr)
AT (1) ATE418549T1 (sr)
AU (1) AU698638B2 (sr)
BR (1) BR9609450A (sr)
CA (1) CA2226184C (sr)
CZ (1) CZ295430B6 (sr)
DE (1) DE69637788D1 (sr)
DK (1) DK0836601T3 (sr)
DZ (1) DZ2057A1 (sr)
EE (1) EE03444B1 (sr)
ES (1) ES2318850T3 (sr)
HK (1) HK1010193A1 (sr)
HR (1) HRP960232A2 (sr)
HU (1) HUP9901717A3 (sr)
IL (1) IL122811A (sr)
IS (1) IS2666B (sr)
MA (1) MA23921A1 (sr)
MY (1) MY114018A (sr)
NO (1) NO313008B1 (sr)
NZ (1) NZ311842A (sr)
PL (1) PL186702B1 (sr)
PT (1) PT836601E (sr)
RS (1) RS49826B (sr)
RU (1) RU2144031C1 (sr)
SA (1) SA96170103B1 (sr)
SI (1) SI0836601T1 (sr)
SK (1) SK284780B6 (sr)
TN (1) TNSN96090A1 (sr)
TR (1) TR199701754T1 (sr)
TW (1) TW444010B (sr)
UA (1) UA49838C2 (sr)
WO (1) WO1997002261A1 (sr)
ZA (1) ZA965205B (sr)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP960232A2 (en) * 1995-07-03 1998-02-28 Astra Ab A process for the optical purification of compounds
US6699885B2 (en) * 1996-01-04 2004-03-02 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and methods of using same
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US6645988B2 (en) 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
EP0983263A1 (en) * 1997-05-30 2000-03-08 Dr. Reddy's Research Foundation Novel benzimidazole derivatives as antiulcer agents, process for their preparation and pharmaceutical compositions containing them
JP2002501897A (ja) * 1998-01-30 2002-01-22 セプラコール, インク. R−ランソプラゾール組成物及び方法
SE9900274D0 (sv) 1999-01-28 1999-01-28 Astra Ab New compound
TWI289557B (en) 1999-06-17 2007-11-11 Takeda Chemical Industries Ltd A crystal of a hydrate of (R)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]sulfinyl]-1H-benzimidazole
DE60020967T2 (de) 1999-06-30 2006-05-04 Takeda Pharmaceutical Co. Ltd. Kristalle von lansoprazole
US6326384B1 (en) 1999-08-26 2001-12-04 Robert R. Whittle Dry blend pharmaceutical unit dosage form
US6312723B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Pharmaceutical unit dosage form
US6316020B1 (en) 1999-08-26 2001-11-13 Robert R. Whittle Pharmaceutical formulations
US6262086B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Pharmaceutical unit dosage form
US6268385B1 (en) 1999-08-26 2001-07-31 Robert R. Whittle Dry blend pharmaceutical formulations
US6262085B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6369087B1 (en) 1999-08-26 2002-04-09 Robert R. Whittle Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6780880B1 (en) 1999-08-26 2004-08-24 Robert R. Whittle FT-Raman spectroscopic measurement
US6312712B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Method of improving bioavailability
DE60131649T2 (de) 2000-05-15 2008-10-30 Takeda Pharmaceutical Co. Ltd. Verfahren zur herstellung eines kristalls
CA2417311C (en) 2000-08-04 2012-07-10 Takeda Chemical Industries, Ltd. Crystalline alkali metal salts of lansoprazole and their production and use
KR20100002278A (ko) 2000-12-01 2010-01-06 다케다 야쿠힌 고교 가부시키가이샤 (r)- 또는 (s)-란소프라졸의 결정
KR100433735B1 (ko) * 2001-06-27 2004-06-04 주식회사 씨트리 결정형 ⅰ을 갖는 란소프라졸의 제조방법
SE0104295D0 (sv) * 2001-12-18 2001-12-18 Astrazeneca Ab New process
US20040006111A1 (en) * 2002-01-25 2004-01-08 Kenneth Widder Transmucosal delivery of proton pump inhibitors
MY148805A (en) 2002-10-16 2013-05-31 Takeda Pharmaceutical Controlled release preparation
US8697094B2 (en) 2002-10-16 2014-04-15 Takeda Pharmaceutical Company Limited Stable solid preparations
DE10254167A1 (de) 2002-11-20 2004-06-09 Icon Genetics Ag Verfahren zur Kontrolle von zellulären Prozessen in Pflanzen
MXPA05005762A (es) 2002-12-06 2005-08-16 Altana Pharma Ag Procedimiento para preparar compuestos activos opticamente puros.
PL375695A1 (en) 2002-12-06 2005-12-12 Altana Pharma Ag Process for preparing (s)-pantoprazole
US20040248942A1 (en) * 2003-02-20 2004-12-09 Bonnie Hepburn Novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid
CA2517714A1 (en) * 2003-02-28 2004-09-10 Ranbaxy Laboratories Limited Polymorphs of s-omeprazole
US20050031700A1 (en) * 2003-07-18 2005-02-10 Sanatarus, Inc. Pharmaceutical formulation and method for treating acid-caused gastrointestinal disorders
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US7005732B2 (en) * 2003-10-21 2006-02-28 Honeywell International Inc. Methods and systems for providing MEMS devices with a top cap and upper sense plate
FR2863609A1 (fr) * 2003-12-15 2005-06-17 Isochem Sa Procede d'enrichissement enantiomerique d'un melange d'enantiomeres d'alpha-aminoacides
SE0400410D0 (sv) * 2004-02-20 2004-02-20 Astrazeneca Ab New compounds
US8906940B2 (en) * 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8815916B2 (en) * 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
EP1768668A2 (en) 2004-06-16 2007-04-04 Tap Pharmaceutical Products, Inc. Multiple ppi dosage form
EP1801110A1 (en) 2005-12-22 2007-06-27 KRKA, tovarna zdravil, d.d., Novo mesto Esomeprazole arginine salt
US7553857B2 (en) 2005-12-23 2009-06-30 Lek Pharmaceuticals D.D. S-omeprazole magnesium
US7786309B2 (en) * 2006-06-09 2010-08-31 Apotex Pharmachem Inc. Process for the preparation of esomeprazole and salts thereof
FR2909380B1 (fr) * 2006-12-04 2009-02-20 Sidem Pharma Sa Sa Conglomerats de sels de potassium de tenatoprazole
EP1947099A1 (en) 2007-01-18 2008-07-23 LEK Pharmaceuticals D.D. Process for solvent removal from omeprazole salts
CN101323609B (zh) * 2007-06-15 2013-05-01 成都福瑞生物工程有限公司 不对称氧化硫醚成亚砜合成对映体含量高的苯并咪唑衍生物的方法
KR101432866B1 (ko) * 2007-06-15 2014-08-26 엠큐어 파마슈티컬즈 리미티드 생활성 화합물의 설폭사이드화 방법
FR2920428B1 (fr) * 2007-08-29 2012-06-15 Univ Rouen Procede de dedoublement de sels de l'omeprazole
PE20091680A1 (es) 2008-03-10 2009-11-16 Takeda Pharmaceutical Cristal de compuestos de bencimidazol
WO2010058409A2 (en) 2008-11-18 2010-05-27 Hetero Research Foundation Optical purification of esomeprazole
KR101001646B1 (ko) * 2008-12-12 2010-12-17 한미약품 주식회사 (r)-(+)-란소프라졸의 제조방법 및 이에 사용되는 중간체
WO2011004387A2 (en) 2009-06-18 2011-01-13 Matrix Laboratories Ltd Process for the preparation of dexlansoprazole polymorphic forms
US8748619B2 (en) 2009-11-12 2014-06-10 Hetero Research Foundation Process for the resolution of omeprazole
AU2011210328A1 (en) 2010-01-29 2012-08-16 Ranbaxy Laboratories Limited Process for the preparation of crystalline forms of dexlansoprazole
US10071996B2 (en) 2014-07-30 2018-09-11 Aetas Pharma Co., Ltd. Optical isomer of 1,4-benzothiazepine-1-oxide derivative, and pharmaceutical composition prepared using same
EP3064495B1 (en) 2015-03-06 2016-12-14 F.I.S.- Fabbrica Italiana Sintetici S.p.A. Improved process for the preparation of optically pure esomeprazole

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7804231L (sv) * 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
JPS6150978A (ja) * 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
AU4640985A (en) * 1984-08-31 1986-03-06 Nippon Chemiphar Co. Ltd. Benzimidazole derivatives
FI90544C (fi) * 1986-11-13 1994-02-25 Eisai Co Ltd Menetelmä lääkeaineina käyttökelpoisten 2-pyridin-2-yyli-metyylitio- ja sulfinyyli-1H-bensimidatsolijohdannaisten valmistamiseksi
ES2057338T3 (es) * 1989-11-29 1994-10-16 Toa Eiyo Ltd Derivados de cicloheptenopiridina, procedimiento para su preparacion y agentes antiulcerosos que los contienen.
DE4035455A1 (de) * 1990-11-08 1992-05-14 Byk Gulden Lomberg Chem Fab Enantiomerentrennung
SE9301830D0 (sv) * 1993-05-28 1993-05-28 Ab Astra New compounds
IS4232A (is) * 1993-12-06 1995-06-07 Astra Aktiebolag Súbstitúerað bensimidasól, aðferðir við framleiðslu þess og lyfjafræðileg notkun
HRP960232A2 (en) * 1995-07-03 1998-02-28 Astra Ab A process for the optical purification of compounds

Also Published As

Publication number Publication date
DK0836601T3 (da) 2009-03-16
IL122811A (en) 2000-11-21
JP4195507B2 (ja) 2008-12-10
UA49838C2 (uk) 2002-10-15
EP1498416A1 (en) 2005-01-19
IS2666B (is) 2010-08-15
SK179397A3 (en) 1998-09-09
EE03444B1 (et) 2001-06-15
JPH11508590A (ja) 1999-07-27
CZ421197A3 (cs) 1998-06-17
HK1010193A1 (en) 1999-06-17
TW444010B (en) 2001-07-01
HUP9901717A2 (hu) 2000-04-28
HRP960232A2 (en) 1998-02-28
IS4638A (is) 1997-12-22
CN1098261C (zh) 2003-01-08
YU37696A (sh) 1999-03-04
SI0836601T1 (sl) 2009-04-30
EP0836601B1 (en) 2008-12-24
EE9700368A (et) 1998-06-15
NZ311842A (en) 1998-12-23
TNSN96090A1 (fr) 2005-03-15
NO976030D0 (no) 1997-12-22
MX9800160A (es) 1998-03-31
KR19990028631A (ko) 1999-04-15
IL122811A0 (en) 1998-08-16
PL324394A1 (en) 1998-05-25
SK284780B6 (sk) 2005-11-03
DE69637788D1 (de) 2009-02-05
WO1997002261A1 (en) 1997-01-23
ES2318850T3 (es) 2009-05-01
RU2144031C1 (ru) 2000-01-10
PT836601E (pt) 2009-02-17
AU6324096A (en) 1997-02-05
HUP9901717A3 (en) 2002-03-28
BR9609450A (pt) 1999-03-02
KR100451078B1 (ko) 2004-11-16
DZ2057A1 (fr) 2002-10-20
EP0836601A1 (en) 1998-04-22
CA2226184C (en) 2008-08-05
NO976030L (no) 1998-02-09
MA23921A1 (fr) 1996-12-31
ZA965205B (en) 1997-01-03
PL186702B1 (pl) 2004-02-27
ATE418549T1 (de) 2009-01-15
US5929244A (en) 1999-07-27
MY114018A (en) 2002-07-31
CN1193971A (zh) 1998-09-23
CA2226184A1 (en) 1997-01-23
NO313008B1 (no) 2002-07-29
TR199701754T1 (xx) 1998-04-21
SA96170103B1 (ar) 2006-07-30
CZ295430B6 (cs) 2005-08-17
AU698638B2 (en) 1998-11-05

Similar Documents

Publication Publication Date Title
RS49826B (sr) Postupak optičkog prečišćavanja preparata obogaćenog enantiomerom omeprazola
DE60033801D1 (de) Uv-härtbare silberzusammensetzung und zugehöriges verfahren
NO20071498L (no) Substituerte acylhydroksamsyrer samt fremgangsmate for a redusere TNFa-nivaet
ZA9510426B (en) Water-based organopolysiloxane-containing compositions processes for their preparation and their use
FI20030932A (fi) Menetelmä cis-FTC:n enantiomeerien erottamiseksi
BR9612358A (pt) Poliamida processo de fabricação de uma poliamida e composição
AR048456A2 (es) Composicion farmaceutica de topiramato
ES2131207T3 (es) Derivados de amidas del acido valproico y 2-valproenoico y su uso como anticonvulsivos.
BR9603809A (pt) Composto composição orgânica estável e processo de melhoramento da atividade estabilizadora de um antidergradante
BR0005683A (pt) Processo para melhorar o tempo de secagem de um revestimento externo
ATE147590T1 (de) Stabilisierte antibiotikum enthaltende tierfutterzusammensetzungen
FI943698A0 (fi) Menetelmä kuitukoostumuksen valmistamiseksi onttojen koristeiden aikaansaamista varten
ES2189730T3 (es) Derivados policiclicos aza-indolinicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
BR9611472A (pt) Compostos de di-terc-butilfenol contendo enxofre úteis como agentes antiinflamatórios
JPS5223017A (en) Process for purification of (meth) acrylic acid or its esters
MX9606494A (es) Compuestos organicos.
ATE172976T1 (de) 3-aminochroman-spiroderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen
ATE183995T1 (de) Herstellung von mit enantiomer angereicherten ortho-substituierten alpha, alpha-diaromatischen methanolen
ATE289583T1 (de) Stereoisomere von propyl-isopropylacetamid, verfahren zu deren herstellung sowie diese enthaltende pharmazeutische zubereitungen
ES8603385A1 (es) Procedimiento para la obtencion de determinadas parejas de enantiomeros de permetrinato de -ciano-3-fenoxi-4-fluorben- cilo
HUP9803017A2 (hu) Benzofuril- és benzotienilszármazékok, eljárás előállításukra és azokat tartalmazó gyógyászati készítmények
AU527894B2 (en) Bis-penicillin esters of alkane diols
ATE16100T1 (de) Ester der 1-methyl-5-p-toluoylpyrrolyl-2essigs|ure mit antiinflammatorischen, mucolytischen und antitussiven eigenschaften, verfahren zu seiner herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ES2095459T3 (es) Derivados ester del antibiotico a 40926.
ES2042409B1 (es) Procedimiento para la preparacion de d-aminoacidos o derivados de d-aminoacidos.